Dr. Ronald Ming Yang, MD

Dr. Yang practices at Kaiser Permanente Medical Group Bellflower Medical Offices - HOPD in Bellflower, California.

Dr. Yang's NPI, 1316095334, was assigned on January 8, 2007. Dr. Yang graduated from Harvard Medical School in 2000. Dr. Yang holds California license A78598.

Dr. Yang's primary practice is Kaiser Permanente Medical Group Bellflower Medical Offices - HOPD, at 9400 Rosecrans Avenue, Bellflower, CA 90706.

Dr. Yang's primary practice is Kaiser Permanente Medical Group Bellflower Medical Offices - HOPD in Bellflower, California. Dr. Yang is also affiliated with Downey Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Yang to 1 more breast imaging center and 1 group practice or clinic, each named with a free account. Dr. Yang's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yang practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Yang's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Yang is board certified in urology by the American Board of Urology. Dr. Yang is licensed in California.

Dmand AI lists enlarged prostate, erectile dysfunction, urinary endoscopy and UTI among the conditions Dr. Yang treats.

CMS data shows 15 Medicare services from Dr. Yang across 1 procedure code in 2024, all of them office visits, for 24 Medicare patients. Medicare paid $618 for them. Every service was in an office.

CMS counts 24 Medicare patients who saw Dr. Yang in 2024. 63% of them have high blood pressure, and 46% have high cholesterol. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yang's median patient age at 66, with 30% women.

In 2024, Dr. Yang wrote 5,368 Medicare Part D claims for 1,339 patients. 99% of them were for generic drugs. CMS names the drug for 5,257 of them, across 17 drugs with 11 or more claims each, at $132,219 in total drug cost. In 2023, CMS named 5,581 claims across 16 drugs.

Dr. Yang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yang as offering telehealth.

Dmand AI links 6 papers to Dr. Yang. The most frequent topics are Nephrostomy, Percutaneous. Dr. Yang has published most often in J Endourol. Dr. Yang's most frequent co-authors are Gary C. Bellman, MD and Sanjoy Bhattacharya, MD.

CMS Open Payments shows 8 general payments to Dr. Yang from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $204.

Dmand AI lists 1 award for Dr. Yang, most recently CMS Stage 1 2012 in 2011.

Dr. Yang graduated from Harvard Medical School in 2000.

Dr. Yang is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.